$SNPS

Synopsys in focus as Morgan Stanley ups price target on AI hopes

Morgan Stanley raised its price target for Synopsys (SNPS) to $574, citing AI-driven expansion. The firm believes Synopsys' valuation discount is unwarranted. Shares fell 0.8% in premarket trading.

Original reporting
Published Oct 20, 2026, 12:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 1:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys in focus as Morgan Stanley ups price target on AI hopes — source image
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

Analyst target raise may attract new buying interest, but execution risk remains.

02

Market read

Target raise highlights AI as a catalyst for Synopsys, potentially influencing EDA sector sentiment.

03

What to watch

Uncertainty around timing and scale of AI revenue accretion could temper upside.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Synopsys recently outlined three AI frameworks at its investor day, positioning AI as a future growth engine.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Morgan Stanley raised Synopsys' price target to $574 from $550, citing AI-driven market expansion.

Expected impact

likely upward pressure as investors price in AI growth expectations

Evidence & confidence

Target increase and overweight rating indicate confidence in future earnings, despite a modest pre‑market dip.

Market effects

AI adoption could broaden the addressable market for electronic design automation firms.

U.S. technology sector may see modest lift from analyst optimism.

AI‑driven growth narrative reinforces broader tech valuations worldwide.

Counterpoint

Shares fell 0.8% pre‑market, suggesting short‑term skepticism about execution risk.

Key entities

  • Morgan Stanley

    Raised price target and reaffirmed Overweight rating.

  • Synopsys

    Electronic design automation firm focusing on AI expansion.

Related articles

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.

$SNPSMed

Morgan Stanley Raises Synopsys (SNPS) Price Target Amid AI Tailw

Morgan Stanley raised Synopsys' (SNPS) price target to $574 from $550, citing AI growth potential. SNPS shares dipped 0.8% premarket. GF Value™ estimates intrinsic value at $661.95, 32.8% above current price. SNPS has a GF Score™ of 93/100, reflecting strong growth and profitability. The stock's P/E ratio is 78.61x, below its 5-year median of 59.07x.